UCHL5 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, we demonstrated that knockdown of USP14 and UCHL5 increased imatinib sensitivity and cell apoptosis in BCR‐ABLWT and BCR‐ABLT315I CML cells.